Skip Nav Destination
Medical consult: aHUS, TTP? How to distinguish and what to do
- Identify patterns of clinical features and use clinical decision tools to distinguish iTTP from aHUS
- Understand the interpretation and application of ADAMTS13 assays for iTTP diagnosis
Current use of CAR T cells to treat multiple myeloma
Learning Objectives
- Discuss practical considerations for CAR T-cell products currently approved by the US Food and Drug Administration and potential expanded indications for those agents
- Explore currently available research regarding challenges with therap
- Evaluate treatment options following relapse from CAR T-cell therapy
Long-term follow-up of CD19-CAR T-cell therapy in children and young adults with B-ALL
Learning Objectives
- Review the current landscape of subacute/delayed toxicities following CAR T-cell therapy
- Identify approaches to evaluation and management of delayed toxicities following CAR T cells
- Recognize the need for study of late effects in long-term survivors following CAR T-cell therapy
